Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Operating Income (2019 - 2025)

Historic Operating Income for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$19.2 million.

  • Korro Bio's Operating Income rose 1740.94% to -$19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.5 million, marking a year-over-year increase of 131.99%. This contributed to the annual value of -$91.9 million for FY2024, which is 872.55% down from last year.
  • Per Korro Bio's latest filing, its Operating Income stood at -$19.2 million for Q3 2025, which was up 1740.94% from -$27.2 million recorded in Q2 2025.
  • Korro Bio's Operating Income's 5-year high stood at $5.8 million during Q4 2022, with a 5-year trough of -$27.2 million in Q2 2025.
  • Its 5-year average for Operating Income is -$20.6 million, with a median of -$21.4 million in 2021.
  • Per our database at Business Quant, Korro Bio's Operating Income soared by 12719.23% in 2022 and then plummeted by 56303.37% in 2023.
  • Quarter analysis of 5 years shows Korro Bio's Operating Income stood at -$21.4 million in 2021, then surged by 127.19% to $5.8 million in 2022, then crashed by 563.03% to -$26.9 million in 2023, then grew by 14.33% to -$23.0 million in 2024, then rose by 16.51% to -$19.2 million in 2025.
  • Its last three reported values are -$19.2 million in Q3 2025, -$27.2 million for Q2 2025, and -$25.0 million during Q1 2025.